ANAsaph Md Nini

Asaph Md Nini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asaph Md Nini has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Amir Gal Oz

    Division of Anaesthesia, Pain Management and Intensive Care, Tel Aviv Sourasky Medical Center, Weizmann 6, Tel Aviv 6423919, Israel

    2 shared publications
  • Andrey Nevo

    Division of Anaesthesia, Pain Management and Intensive Care, Tel Aviv Sourasky Medical Center, Weizmann 6, Tel Aviv 6423919, Israel

    2 shared publications
  • Dekel Stavi

    Division of Anesthesia, Pain Management, and Intensive Care, Tel-Aviv Sourasky Medical Center—Ichilov Hospital, Faculty of Medicine, University of Tel Aviv, Tel Aviv 64239, Israel

    2 shared publications
  • Itay Moshkovits

    Division of Anaesthesia, Pain Management and Intensive Care, Tel Aviv Sourasky Medical Center, Weizmann 6, Tel Aviv 6423919, Israel

    2 shared publications
  • Nimrod Adi

    Division of Anaesthesia, Pain Management and Intensive Care, Tel Aviv Sourasky Medical Center, Weizmann 6, Tel Aviv 6423919, Israel

    2 shared publications
  • Noam Goder

    Ross Tilley Burn Centre, Sunnybrook HSC, Toronto, Canada; Division of Plastic, Reconstructive and Aesthetic Surgery, Department of Surgery, University of Toronto, Toronto, Canada

    2 shared publications

Latest Publications

  • Open Access

    Short-Term Reactions to Oliguria in Critically Ill Patients: A Retrospective Cohort Study

    by Dekel Stavi, Amir Gal Oz, Nimrod Adi, Asaph Nini, Yoel Angel, Andrey Nevo, Daniel Aviram, Itay Moshkovits, Yael Lichter, Ron Wald, et al.

    Background/Objective: Oliguria is common in critically ill patients and may indicate impaired kidney perfusion or acute injury, contributing to increased mortality. Effective management is essential to improve outcomes. To assess clinician reactions to oliguria and evaluate the effectiveness of fluid bolus and furosemide interventions. Methods: A retrospective cohort study was conducted using ICU data from a single center (2017–2023). Oliguria was defined as two consecutive hours of urine output < 20 mL/h following at least three hours > 20 mL/h. Clinicians’ reactions within four hours were categorized as no intervention, fluid bolus (>250 mL), or furosemide administration. Outcomes included urine output, fluid balance, and serum creatinine. Results: Among 4987 oliguria episodes, 4007 events in 1825 patients were analyzed: no reaction (2536), fluid bolus (923), and furosemide (548). Furosemide significantly increased urine output (53.9 to 75.3 mL/h, p < 0.001), while fluid bolus had no significant effect. Resolution of oliguria (mean urine output > 40 mL/h for 5 h post-intervention) was more frequent with furosemide (66.4%) than with fluid bolus (28.4%) or no reaction (27.6%) (p < 0.001). Treatment choices varied significantly among ICU attendings (p < 0.001). Conclusions: Furosemide was more effective than fluid bolus or no treatment in improving urine output and resolving oliguria. The observed variation in clinician practices underscores the need for standardized management protocols to enhance patient care.


  • Open Access

    Linear Correlation Between Mean Arterial Pressure and Urine Output in Critically Ill Patients

    by Yael Lichter, Amir Md Gal Oz, Nimrod Adi, Asaph Md Nini, Yoel Md Angel, Andrey Nevo, Daniel Aviram, Itay Moshkovits, Ron Mdcm Wald, Dekel Stavi, et al.

    OBJECTIVE: Mean arterial pressure (MAP) plays a significant role in regulating tissue perfusion and urine output (UO). The optimal MAP target in critically ill patients remains a subject of debate. We aimed to explore the relationship between MAP and UO. DESIGN: A retrospective observational study. SETTING: A general ICU in a tertiary medical center. PATIENTS: All critically ill patients admitted to the ICU for more than 10 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: MAP values and hourly UO were collected in 5,207 patients. MAP levels were categorized into 10 groups of 5 mm Hg (from MAP < 60 mm Hg to MAP > 100 mg Hg), and 656,423 coupled hourly mean MAP and UO measurements were analyzed. Additionally, we compared the UO of individual patients in each MAP group with or without norepinephrine (NE) support or diuretics, as well as in patients with acute kidney injury (AKI). Hourly UO rose incrementally between MAP values of 65–100 mm Hg. Among 2,226 patients treated with NE infusion, mean UO was significantly lower in the MAP less than 60 mm Hg group (53.4 mL/hr; 95% CI, 49.3–57.5) compared with all other groups (p < 0.001), but no differences were found between groups of 75 less than or equal to MAP. Among 2500 patients with AKI, there was a linear increase in average UO from the MAP less than 60 mm Hg group (57.1 mL/hr; 95% CI, 54.2–60.0) to the group with MAP greater than or equal to 100 mm Hg (89.4 mL/hr; 95% CI, 85.7–93.1). When MAP was greater than or equal to 65 mm Hg, we observed a statistically significant trend of increased UO in periods without NE infusion. CONCLUSIONS: Our analysis revealed a linear correlation between MAP and UO within the range of 65–100 mm Hg, also observed in the subgroup of patients treated with NE or diuretics and in those with AKI. These findings highlight the importance of tissue perfusion to the maintenance of diuresis and achieving adequate fluid balance in critically ill patients.